Search

Your search keyword '"Amelin D"' showing total 77 results

Search Constraints

Start Over You searched for: Author "Amelin D" Remove constraint Author: "Amelin D"
77 results on '"Amelin D"'

Search Results

51. ATLAS computing technical proposal

52. ATLAS: Technical proposal for a general-purpose p p experiment at the Large Hadron Collider at CERN

53. ATLAS: Detector and physics performance technical design report. Volume 2

54. ATLAS: technical proposal for a general-purpose p p experiment at the large hadron collider at CERN

55. ATLAS calorimeter performance Technical Design Report

56. Antiproton annihilation on nuclei

57. Differential cross-sections of the charge exchange reaction Pi-p-->Pi0 n in the momentum range from 148 MeV/c to 323 MeV/c

58. New Results on Baryon Spectroscopy with the Crystal Ball Spectrometer

59. Measurement of differential cross-sectuibs if tge reaction Pi- p-->eta n using the Crystal Ball detector

60. Radiative transitions in mesons within a non relativistic quark model

61. Mass cytometry reveals atypical immune profile notably impaired maturation of memory CD4 T with Gb3-related CD27 expression in CD4 T cells in Fabry disease.

62. Publisher Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis.

63. Author Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis.

64. Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis.

65. Myostatin in idiopathic inflammatory myopathies: Serum assessment and disease activity.

66. Skeletal muscle provides the immunological micro-milieu for specific plasma cells in anti-synthetase syndrome-associated myositis.

67. Sphingosine-1-Phosphate Levels Are Higher in Male Patients with Non-Classic Fabry Disease.

68. Sirolimus for treatment of patients with inclusion body myositis: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2b trial.

69. Cytokine profile as a prognostic tool in coronavirus disease 2019. Comment on "Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome" by Quartuccio et al. Joint Bone Spine. 2020;87:191-93.

70. Cornea verticillata and acroparesthesia efficiently discriminate clusters of severity in Fabry disease.

71. CD8+ T-bet+ cells as a predominant biomarker for inclusion body myositis.

72. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.

73. Deep characterization of the anti-drug antibodies developed in Fabry disease patients, a prospective analysis from the French multicenter cohort FFABRY.

74. JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis.

75. Necrosis in anti-SRP + and anti-HMGCR + myopathies: Role of autoantibodies and complement.

76. Pathogenic role of anti-signal recognition protein and anti-3-Hydroxy-3-methylglutaryl-CoA reductase antibodies in necrotizing myopathies: Myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies.

77. Long-term exposure to Myozyme results in a decrease of anti-drug antibodies in late-onset Pompe disease patients.

Catalog

Books, media, physical & digital resources